RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
RRAS 和 RRAS2 突变是肺癌中常见的致癌驱动因素,并且对泛 RAS 抑制剂 RMC-6236 敏感。
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-2734
Pfeil, Alexander J; Zhang, Tom; Cheng, Ryan; Mattar, Marissa S; Gomez Marti, Juan Luis; Gili, Leo; Lai, Rachel; Khodos, Inna; Master, Rohan P; Dix, Jenna-Marie; Gazzo, Andrea; Arbour, Kathryn C; de Stanchina, Elisa; Febres-Aldana, Christopher A; Ladanyi, Marc; Yang, Soo-Ryum; Somwar, Romel